Involvement of genetic factors in the response to a variable-dosing ranibizumab treatment regimen for age-related macular degeneration

PURPOSE: To determine whether gene polymorphisms of the major genetic risk factor for age-related macular susceptibility 2 (ARMS2 A69S) and the complement factor H Y402H influence the response to a variable-dosing treatment regimen with ranibizumab for age-related macular degeneration. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Teper, Slawomir J., Nowinska, Anna, Pilat, Jaroslaw, Palucha, Andrzej, Wylegala, Edward
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000236/
https://www.ncbi.nlm.nih.gov/pubmed/21151600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000236/
https://www.ncbi.nlm.nih.gov/pubmed/21151600

Ejemplares similares